Annual Long Term Debt
$436.74 M
-$6.83 M-1.54%
December 31, 2023
Summary
- As of February 7, 2025, FOLD annual long term debt is $436.74 million, with the most recent change of -$6.83 million (-1.54%) on December 31, 2023.
- During the last 3 years, FOLD annual long term debt has risen by +$1.88 million (+0.43%).
- FOLD annual long term debt is now -1.54% below its all-time high of $443.57 million, reached on December 31, 2022.
Performance
FOLD Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$436.12 M
+$171.00 K+0.04%
September 30, 2024
Summary
- As of February 7, 2025, FOLD quarterly long term debt is $436.12 million, with the most recent change of +$171.00 thousand (+0.04%) on September 30, 2024.
- Over the past year, FOLD quarterly long term debt has dropped by -$10.41 million (-2.33%).
- FOLD quarterly long term debt is now -2.33% below its all-time high of $446.52 million, reached on September 30, 2023.
Performance
FOLD Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
FOLD Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.5% | -2.3% |
| 3 y3 years | +0.4% | -2.3% |
| 5 y5 years | +35.7% | -2.3% |
FOLD Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -1.5% | +0.9% | -2.3% | +0.8% |
| 5 y | 5-year | -1.5% | +115.1% | -2.3% | +125.2% |
| alltime | all time | -1.5% | >+9999.0% | -2.3% | >+9999.0% |
Amicus Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $436.12 M(+0.0%) |
| Jun 2024 | - | $435.95 M(-0.1%) |
| Mar 2024 | - | $436.22 M(-0.1%) |
| Dec 2023 | $436.74 M(-1.5%) | $436.74 M(-2.2%) |
| Sep 2023 | - | $446.52 M(+0.5%) |
| Jun 2023 | - | $444.33 M(+0.1%) |
| Mar 2023 | - | $444.01 M(+0.1%) |
| Dec 2022 | $443.57 M(+2.5%) | $443.57 M(+0.1%) |
| Sep 2022 | - | $443.33 M(-0.0%) |
| Jun 2022 | - | $443.50 M(+0.7%) |
| Mar 2022 | - | $440.45 M(+1.8%) |
| Dec 2021 | $432.72 M(-0.5%) | $432.72 M(+0.1%) |
| Sep 2021 | - | $432.21 M(-0.6%) |
| Jun 2021 | - | $434.63 M(+0.1%) |
| Mar 2021 | - | $434.22 M(-0.1%) |
| Dec 2020 | $434.86 M(+114.2%) | $434.86 M(+0.4%) |
| Sep 2020 | - | $433.21 M(+123.6%) |
| Jun 2020 | - | $193.70 M(-4.2%) |
| Mar 2020 | - | $202.26 M(-0.4%) |
| Dec 2019 | $203.04 M(-36.9%) | $203.04 M(+2.1%) |
| Sep 2019 | - | $198.95 M(+7.4%) |
| Jun 2019 | - | $185.32 M(-9.6%) |
| Mar 2019 | - | $204.92 M(-36.3%) |
| Dec 2018 | $321.74 M(+96.0%) | $321.74 M(+0.9%) |
| Sep 2018 | - | $318.81 M(+88.2%) |
| Jun 2018 | - | $169.44 M(+1.6%) |
| Mar 2018 | - | $166.77 M(+1.6%) |
| Dec 2017 | $164.17 M(+6.3%) | $164.17 M(+1.6%) |
| Sep 2017 | - | $161.63 M(+1.5%) |
| Jun 2017 | - | $159.17 M(+1.5%) |
| Mar 2017 | - | $156.86 M(+1.6%) |
| Dec 2016 | $154.46 M(+271.3%) | $154.46 M(+134.0%) |
| Sep 2016 | - | $66.02 M(+1.1%) |
| Jun 2016 | - | $65.29 M(+69.6%) |
| Mar 2016 | - | $38.51 M(-7.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $41.60 M(+295.8%) | $41.60 M(-16.8%) |
| Sep 2015 | - | $50.00 M(+443.0%) |
| Mar 2015 | - | $9.21 M(-12.4%) |
| Dec 2014 | $10.51 M(-25.9%) | $10.51 M(-11.0%) |
| Sep 2014 | - | $11.81 M(-9.9%) |
| Jun 2014 | - | $13.10 M(-7.8%) |
| Mar 2014 | - | $14.22 M(+0.3%) |
| Dec 2013 | $14.17 M(+4640.5%) | $14.17 M(>+9900.0%) |
| Jun 2013 | - | $100.00 K(-49.7%) |
| Mar 2013 | - | $199.00 K(-33.4%) |
| Dec 2012 | $299.00 K(-71.4%) | $299.00 K(-24.9%) |
| Sep 2012 | - | $398.00 K(-20.1%) |
| Jun 2012 | - | $498.00 K(-16.6%) |
| Mar 2012 | - | $597.00 K(+474.0%) |
| Sep 2011 | - | $104.00 K(-75.1%) |
| Jun 2011 | - | $418.00 K(-42.8%) |
| Mar 2011 | - | $731.00 K(-30.0%) |
| Dec 2010 | $1.04 M(-55.5%) | $1.04 M(-23.1%) |
| Sep 2010 | - | $1.36 M(-18.7%) |
| Jun 2010 | - | $1.67 M(-16.8%) |
| Mar 2010 | - | $2.01 M(-14.4%) |
| Dec 2009 | $2.34 M(+639.4%) | $2.34 M(-13.1%) |
| Sep 2009 | - | $2.70 M(+25.3%) |
| Jun 2009 | - | $2.15 M(+864.6%) |
| Mar 2009 | - | $223.00 K(-29.7%) |
| Dec 2008 | $317.00 K(-73.5%) | $317.00 K(-34.4%) |
| Sep 2008 | - | $483.00 K(-30.5%) |
| Jun 2008 | - | $695.00 K(-24.3%) |
| Mar 2008 | - | $918.00 K(-23.1%) |
| Dec 2007 | $1.19 M(-47.1%) | $1.19 M(-24.1%) |
| Sep 2007 | - | $1.57 M(-19.5%) |
| Jun 2007 | - | $1.95 M(+2.4%) |
| Mar 2007 | - | $1.91 M(-15.5%) |
| Dec 2006 | $2.26 M(+207.2%) | $2.26 M(+207.2%) |
| Dec 2005 | $734.40 K | $734.40 K |
FAQ
- What is Amicus Therapeutics annual long term debt?
- What is the all time high annual long term debt for Amicus Therapeutics?
- What is Amicus Therapeutics annual long term debt year-on-year change?
- What is Amicus Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly long term debt year-on-year change?
What is Amicus Therapeutics annual long term debt?
The current annual long term debt of FOLD is $436.74 M
What is the all time high annual long term debt for Amicus Therapeutics?
Amicus Therapeutics all-time high annual long term debt is $443.57 M
What is Amicus Therapeutics annual long term debt year-on-year change?
Over the past year, FOLD annual long term debt has changed by -$6.83 M (-1.54%)
What is Amicus Therapeutics quarterly long term debt?
The current quarterly long term debt of FOLD is $436.12 M
What is the all time high quarterly long term debt for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly long term debt is $446.52 M
What is Amicus Therapeutics quarterly long term debt year-on-year change?
Over the past year, FOLD quarterly long term debt has changed by -$10.41 M (-2.33%)